Truist Financial Corp lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 12.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,377 shares of the company’s stock after acquiring an additional 1,899 shares during the period. Truist Financial Corp’s holdings in Privia Health Group were worth $400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently modified their holdings of the company. Covestor Ltd raised its position in Privia Health Group by 8.3% during the third quarter. Covestor Ltd now owns 6,703 shares of the company’s stock worth $154,000 after acquiring an additional 514 shares during the period. International Assets Investment Management LLC boosted its position in shares of Privia Health Group by 2,721.7% during the fourth quarter. International Assets Investment Management LLC now owns 7,139 shares of the company’s stock worth $164,000 after buying an additional 6,886 shares during the period. Assetmark Inc. increased its stake in Privia Health Group by 17.6% during the third quarter. Assetmark Inc. now owns 7,384 shares of the company’s stock worth $170,000 after purchasing an additional 1,107 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Privia Health Group by 30.7% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 8,214 shares of the company’s stock worth $189,000 after buying an additional 1,928 shares during the period. Finally, Baron Wealth Management LLC purchased a new stake in shares of Privia Health Group during the fourth quarter worth $237,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.
Privia Health Group Trading Down 0.6 %
Shares of PRVA stock opened at $16.90 on Friday. The company has a market capitalization of $2.02 billion, a price-to-earnings ratio of 112.67, a PEG ratio of 2.26 and a beta of 0.81. The firm has a 50-day moving average price of $18.87 and a 200 day moving average price of $20.82. Privia Health Group, Inc. has a twelve month low of $16.80 and a twelve month high of $29.42.
Privia Health Group (NASDAQ:PRVA – Get Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). The firm had revenue of $440.80 million during the quarter, compared to analyst estimates of $425.81 million. Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. The business’s quarterly revenue was up 21.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.14 EPS. As a group, research analysts predict that Privia Health Group, Inc. will post 0.24 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on PRVA. Jefferies Financial Group began coverage on Privia Health Group in a research note on Monday, February 26th. They set a “buy” rating and a $25.00 target price for the company. Bank of America cut Privia Health Group from a “buy” rating to a “neutral” rating and reduced their price target for the company from $27.00 to $21.00 in a report on Thursday, February 22nd. Citigroup began coverage on Privia Health Group in a report on Monday, April 22nd. They set a “buy” rating and a $25.00 price objective on the stock. Stifel Nicolaus reduced their target price on Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Finally, UBS Group lowered their price target on shares of Privia Health Group from $31.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, March 1st. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Privia Health Group currently has a consensus rating of “Moderate Buy” and an average target price of $25.33.
Get Our Latest Stock Report on Privia Health Group
Insider Transactions at Privia Health Group
In related news, CEO Parth Mehrotra sold 13,869 shares of the stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $17.88, for a total transaction of $247,977.72. Following the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,430,145.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Parth Mehrotra sold 13,869 shares of the company’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $17.88, for a total transaction of $247,977.72. Following the completion of the transaction, the chief executive officer now owns 247,771 shares of the company’s stock, valued at approximately $4,430,145.48. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO David Mountcastle sold 2,320 shares of the firm’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $42,734.40. Following the completion of the sale, the chief financial officer now directly owns 259,959 shares in the company, valued at $4,788,444.78. The disclosure for this sale can be found here. Insiders have sold 49,390 shares of company stock worth $897,700 over the last quarter. 14.20% of the stock is currently owned by insiders.
About Privia Health Group
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
Receive News & Ratings for Privia Health Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Privia Health Group and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
